Selskabets formål er at købe, sælge, handle (hvad enten som agent eller andet), eksportere, importere, vedligeholde, inspicere, afprøve, montere og fremstille medicinske og farmaceutiske produkter samt udvikle, producere og markedsføre teknologi i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser eller assistance, herunder af administrativ, driftsmæssig, finansiel, videnskabelig eller industriel karakter, i tilknytning til selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selskaber.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 192 mio. | 7.9 mio. | 187.6 mio. | 140.1 mio. | 22 | |
CVR: 17558501
Previous names: P.P.H.S.G. 209 A/S, ST. JUDE MEDICAL DANMARK A/S
Companies in the same industry and area
CVR 30234189
CVR 45320618
CVR 13902992
CVR 27478700
CVR 51619811
Compared to 288 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Abbott Medical Danmark A/S demonstrates a stable financial health with a consistent revenue stream and increasing profitability over the past few years. In 2024, the company reported revenue of 191.99 million DKK and a profit of 7.90 million DKK, reflecting a growth trend from 185.83 million DKK in revenue and 7.06 million DKK in profit in 2023. The equity position has also improved, rising to 140.10 million DKK in 2024 from 132.20 million DKK the previous year, indicating a solid foundation for future growth. However, revenue has declined from a peak of 239.64 million DKK in 2021, which may raise concerns about market positioning within the medical supplies industry. Overall, the company maintains a strong presence, but attention to revenue stabilization is warranted.
AI-generated summary
companydata.dk